Tokuyama Corporation falls sharply after three-day gain on uncertain outlook amid Middle East tensions

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Tue Apr 28, 2026 10:56 am JST Catalyst

Tokuyama Corporation <4043> fell sharply, snapping a three-day winning streak after the company withheld its earnings guidance. Reporting its consolidated results for the fiscal year ended March 2026 at 9:00 a.m. on April 28, Tokuyama said sales rose 1.9% year-on-year to 349.48 billion yen and ordinary profit climbed 29.1% to a record 38.20 billion yen, while net profit fell 5.1% to 22.21 billion yen. Although ordinary profit reached a record high, sales and profit lines missed previous company forecasts. Citing heightened Middle East tensions, Tokuyama left its forecast for the fiscal year ending March 2027 undecided, sparking selling pressure on outlook concerns.

For the year ended March 2026, the consolidation of Tokuyama Life Science and higher semiconductor-related sales bolstered results, alongside manufacturing cost improvements. For the fiscal year ending March 2027, the company expects the advanced semiconductor sector to remain solid but warned of rising uncertainty regarding raw material procurement and costs. Tokuyama stated it would announce a forecast once a reliable estimate becomes possible.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.